Picture loading failed.

Anti-IL12B therapeutic antibody (Pre-made Ustekinumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Ustekinumab, sold under the brand name Stelara?, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis, targeting both IL-12 and IL-23.

Order informatioin

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-605-1mg 1mg 3090
GMP-Bios-ab-605-10mg 10mg 21890
GMP-Bios-ab-605-100mg 100mg 148000
GMP-Bios-ab-605-xmg >100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-IL12B therapeutic antibody (Pre-made Ustekinumab biosimilar,Whole mAb)
INN Name Ustekinumab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved
Est. StatusActive
100% SI Structure3hmw:HL/3hmx:HL
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2008
Year Recommended2009
CompaniesCentocor Inc;Janssen Biotech;Medarex
Conditions ApprovedCrohn's disease;Plaque psoriasis;Psoriatic arthritis
Conditions ActiveUlcerative colitis;Spondylarthritis;Systemic lupus erythematosus;Atopic dermatitis
Conditions DiscontinuedMultiple sclerosis;Palmoplantar pustulosis;Primary biliary cirrhosis;Rheumatoid arthritis;Sarcoidosis
Development TechMedarex UltiMAb Mouse